192 related articles for article (PubMed ID: 32907912)
1. Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer.
Ichinoe M; Mikami T; Yanagisawa N; Yoshida T; Hana K; Endou H; Okayasu I; Sengoku N; Ogata H; Saegusa M; Shibuya K; Murakumo Y
J Clin Pathol; 2021 Sep; 74(9):589-595. PubMed ID: 32907912
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of CD98 heavy chain and L-type amino acid transporter 1 and its prognostic significance in colorectal cancer.
Lee D; Kim HS; Kim HU; Song HJ; Lee C; Kim DY; Chun HM; Jang WY; Jang B
Pathol Res Pract; 2022 Jan; 229():153730. PubMed ID: 34942513
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
Toyoda M; Kaira K; Ohshima Y; Ishioka NS; Shino M; Sakakura K; Takayasu Y; Takahashi K; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
Br J Cancer; 2014 May; 110(10):2506-13. PubMed ID: 24762957
[TBL] [Abstract][Full Text] [Related]
4. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.
Lee Y; Wiriyasermkul P; Jin C; Quan L; Ohgaki R; Okuda S; Kusakizako T; Nishizawa T; Oda K; Ishitani R; Yokoyama T; Nakane T; Shirouzu M; Endou H; Nagamori S; Kanai Y; Nureki O
Nat Struct Mol Biol; 2019 Jun; 26(6):510-517. PubMed ID: 31160781
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in human bronchial epithelial cells.
Le Vee M; Jouan E; Lecureur V; Fardel O
Toxicol Appl Pharmacol; 2016 Jan; 290():74-85. PubMed ID: 26621329
[TBL] [Abstract][Full Text] [Related]
6. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A
Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494
[TBL] [Abstract][Full Text] [Related]
7. Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis.
Furuya M; Horiguchi J; Nakajima H; Kanai Y; Oyama T
Cancer Sci; 2012 Feb; 103(2):382-9. PubMed ID: 22077314
[TBL] [Abstract][Full Text] [Related]
8. Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer.
Kurozumi S; Kaira K; Matsumoto H; Kurosumi M; Yokobori T; Kanai Y; Sekine C; Honda C; Katayama A; Furuya M; Shiino S; Makiguchi T; Mongan NP; Rakha EA; Oyama T; Fujii T; Shirabe K; Horiguchi J
Sci Rep; 2022 Feb; 12(1):2742. PubMed ID: 35177712
[TBL] [Abstract][Full Text] [Related]
9. LAT1 (SLC7A5) and CD98hc (SLC3A2) complex dynamics revealed by single-particle cryo-EM.
Chiduza GN; Johnson RM; Wright GSA; Antonyuk SV; Muench SP; Hasnain SS
Acta Crystallogr D Struct Biol; 2019 Jul; 75(Pt 7):660-669. PubMed ID: 31282475
[TBL] [Abstract][Full Text] [Related]
10. LAT1 (SLC7A5) Overexpression in Negative Her2 Group of Breast Cancer: A Potential Therapy Target.
Bodoor K; Almomani R; Alqudah M; Haddad Y; Samouri W
Asian Pac J Cancer Prev; 2020 May; 21(5):1453-1458. PubMed ID: 32458655
[TBL] [Abstract][Full Text] [Related]
11. Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.
Okubo S; Zhen HN; Kawai N; Nishiyama Y; Haba R; Tamiya T
J Neurooncol; 2010 Sep; 99(2):217-25. PubMed ID: 20091333
[TBL] [Abstract][Full Text] [Related]
12. Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.
Ogawa H; Kaira K; Motegi Y; Yokobori T; Takada T; Katoh R; Osone K; Takahashi R; Katayama C; Oyama T; Kanai Y; Yao T; Asao T; Kuwano H; Shirabe K
Anticancer Res; 2019 May; 39(5):2535-2543. PubMed ID: 31092450
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer.
Kaira K; Sunose Y; Ohshima Y; Ishioka NS; Arakawa K; Ogawa T; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Itoh H; Nagamori S; Kanai Y; Yamaguchi A; Segawa A; Ide M; Mori M; Oyama T; Takeyoshi I
BMC Cancer; 2013 Oct; 13():482. PubMed ID: 24131658
[TBL] [Abstract][Full Text] [Related]
14. Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.
Kaira K; Kawashima O; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Sugano M; Yamamoto R; Osaki T; Tanaka S; Fujita A; Imai H; Kogure Y; Seki Y; Shimizu K; Mogi A; Shitara Y; Oyama T; Kanai Y; Asao T
Hum Pathol; 2019 Feb; 84():142-149. PubMed ID: 30300664
[TBL] [Abstract][Full Text] [Related]
15. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
[TBL] [Abstract][Full Text] [Related]
16. L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.
Ichinoe M; Yanagisawa N; Mikami T; Hana K; Nakada N; Endou H; Okayasu I; Murakumo Y
Pathol Res Pract; 2015 Jul; 211(7):533-8. PubMed ID: 25908107
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
[TBL] [Abstract][Full Text] [Related]
18. Correlation of high LAT1 expression with the prognosis of endometrioid carcinoma of the uterine corpus.
Sato K; Miyamoto M; Takano M; Tsuda H
Virchows Arch; 2020 Sep; 477(3):421-427. PubMed ID: 32144539
[TBL] [Abstract][Full Text] [Related]
19. Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
Alfarsi LH; El-Ansari R; Craze ML; Masisi BK; Mohammed OJ; Ellis IO; Rakha EA; Green AR
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093034
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
